• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对甲型肝炎旅行健康指南的依从性:荷兰旅行家庭的横断面血清流行率研究——荷兰旅行疫苗接种研究(DiVeST)。

Adherence to hepatitis A travel health guidelines: A cross-sectional seroprevalence study in Dutch travelling families - The Dutch travel Vaccination Study (DiVeST).

作者信息

Doornekamp Laura, GeurtsvanKessel Corine, Slobbe Lennert, Te Marvelde Merel R, Scherbeijn Sandra M J, van Genderen Perry J J, van Gorp Eric C M, Goeijenbier Marco

机构信息

Department of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands; Travel Clinic, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Department of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

出版信息

Travel Med Infect Dis. 2019 Nov-Dec;32:101511. doi: 10.1016/j.tmaid.2019.101511. Epub 2019 Nov 5.

DOI:10.1016/j.tmaid.2019.101511
PMID:31704482
Abstract

BACKGROUND

This Dutch travel Vaccination Study (DiVeST) aimed to study adherence or compliance to Dutch travel health guidelines in travelling families and to identify risk groups to provide better advice and protection for international travellers.

METHODS

Between 2016 and 2018, family members who travelled to Eastern Europe or outside Europe during the preceding year were recruited via Dutch secondary schools. The vaccination status of the travellers was assessed using questionnaires and vaccination records and hepatitis A virus antibody concentrations in dried blood spot (DBS) eluates. Subgroups of travellers with lower adherence to guidelines were identified.

RESULTS

Of the 246 travellers that participated in this study, 155 (63%) travelled to destinations for which the HAV vaccination was recommended. Of these 155 travellers, 56 (36%) said they visited a pre-travel clinic, and 64 of them (41%) showed a valid HAV vaccination in their vaccination records. Of the 145 travellers with available DBS eluates, anti-HAV antibodies were detected in 98 (68%) of them.

CONCLUSIONS

We found that adherence to travel health guidelines, in terms of HAV vaccination, was suboptimal. According to our results, specific attention should be paid to children, persons visiting friends and relatives and those who travel relatively short distances.

摘要

背景

这项荷兰旅行疫苗接种研究(DiVeST)旨在研究旅行家庭对荷兰旅行健康指南的依从性或遵守情况,并确定风险群体,以便为国际旅行者提供更好的建议和保护。

方法

在2016年至2018年期间,通过荷兰中学招募了前一年前往东欧或欧洲以外地区旅行的家庭成员。通过问卷调查、疫苗接种记录以及干血斑(DBS)洗脱液中的甲型肝炎病毒抗体浓度来评估旅行者的疫苗接种状况。确定了对指南依从性较低的旅行者亚组。

结果

在参与本研究的246名旅行者中,155人(63%)前往了推荐接种甲型肝炎疫苗的目的地。在这155名旅行者中,56人(36%)表示他们去过旅行前诊所,其中64人(41%)的疫苗接种记录显示有有效的甲型肝炎疫苗接种。在145名有可用DBS洗脱液的旅行者中,98人(68%)检测到抗甲型肝炎抗体。

结论

我们发现,在甲型肝炎疫苗接种方面,对旅行健康指南的依从性欠佳。根据我们的研究结果,应特别关注儿童、探亲访友者以及旅行距离相对较短的人。

相似文献

1
Adherence to hepatitis A travel health guidelines: A cross-sectional seroprevalence study in Dutch travelling families - The Dutch travel Vaccination Study (DiVeST).对甲型肝炎旅行健康指南的依从性:荷兰旅行家庭的横断面血清流行率研究——荷兰旅行疫苗接种研究(DiVeST)。
Travel Med Infect Dis. 2019 Nov-Dec;32:101511. doi: 10.1016/j.tmaid.2019.101511. Epub 2019 Nov 5.
2
Measles seroprevalence among Dutch travelling families.荷兰旅行家庭麻疹血清流行率。
Travel Med Infect Dis. 2021 Nov-Dec;44:102194. doi: 10.1016/j.tmaid.2021.102194. Epub 2021 Oct 30.
3
Hepatitis B risks and immunisation coverage amongst Australians travelling to southeast Asia and east Asia.前往东南亚和东亚的澳大利亚人乙型肝炎风险和免疫接种率。
Travel Med Infect Dis. 2009 Nov;7(6):344-9. doi: 10.1016/j.tmaid.2009.03.008. Epub 2009 May 9.
4
Hepatitis B immunisation in travellers: poor risk perception and inadequate protection.旅行者中的乙型肝炎免疫接种:风险认知不足与保护措施不力。
Travel Med Infect Dis. 2008 Sep;6(5):315-20. doi: 10.1016/j.tmaid.2008.05.001.
5
Trends in the knowledge, attitudes and practices of travel risk groups toward prevention of hepatitis B: results from the repeated cross-sectional Dutch Schiphol Airport Survey 2002-2009.旅行风险群体对乙型肝炎预防的知识、态度和行为趋势:来自荷兰史基浦机场 2002-2009 年重复横断面调查的结果。
Travel Med Infect Dis. 2014 Mar-Apr;12(2):149-58. doi: 10.1016/j.tmaid.2013.09.002. Epub 2013 Sep 29.
6
Travellers' profile, travel patterns and vaccine practices--a 10-year prospective study in a Swiss Travel Clinic.旅行者特征、旅行模式和疫苗接种实践——瑞士旅行诊所的一项 10 年前瞻性研究。
J Travel Med. 2016 Jan 20;23(1). doi: 10.1093/jtm/tav017. Print 2016 Jan.
7
Pre-travel health care attendance among migrant travellers visiting friends and relatives (VFR): a 10-year retrospective analysis.流动人口中探亲访友旅行者(VFR)的旅行前保健就诊情况:一项为期 10 年的回顾性分析。
BMC Public Health. 2019 Oct 28;19(1):1397. doi: 10.1186/s12889-019-7722-0.
8
HAV & HBV vaccination among travellers participating in the National Health and Wellness Survey in five European countries.旅行者在五个欧洲国家参与国家健康和健康调查中的 HAV 和 HBV 疫苗接种情况。
Travel Med Infect Dis. 2016 May-Jun;14(3):221-32. doi: 10.1016/j.tmaid.2016.03.008. Epub 2016 Mar 19.
9
Changes to country-specific hepatitis A travel vaccination recommendation for UK travellers in 2017-responding to a vaccine shortage in the national context.2017 年英国旅行者针对特定国家的甲型肝炎旅行疫苗接种建议的变化 - 应对国家范围内的疫苗短缺。
Public Health. 2019 Mar;168:150-156. doi: 10.1016/j.puhe.2018.09.017. Epub 2018 Nov 12.
10
Risk factors and pre-travel healthcare of international travellers attending a Dutch travel clinic: a cross-sectional analysis.国际旅行者在荷兰旅行诊所就诊的风险因素和旅行前医疗保健:横断面分析。
Travel Med Infect Dis. 2014 Sep-Oct;12(5):511-24. doi: 10.1016/j.tmaid.2014.05.004. Epub 2014 May 28.

引用本文的文献

1
Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment.甲型肝炎:流行病学、高危人群、预防和抗病毒治疗研究。
Viruses. 2021 Sep 22;13(10):1900. doi: 10.3390/v13101900.
2
A Study of Hepatitis A Seroprevalence in a Paediatric and Adolescent Population of the Province of Florence (Italy) in the Period 2017-2018 Confirms Tuscany a Low Endemic Area.一项关于2017 - 2018年意大利佛罗伦萨省儿童和青少年人群甲型肝炎血清流行率的研究证实托斯卡纳为低流行地区。
Vaccines (Basel). 2021 Oct 17;9(10):1194. doi: 10.3390/vaccines9101194.